We are close to reaching the point that Cytodyn can't be ignored. Mono or cancer makes leronlimab a billion dollar drug. Cydy is asking for $90M + commercialization for 50% cut. BP is not use to giving that big of a cut, but 50% of a billion dollar drug is better than 80% of nothing. That is why cydy is selling, which the science continues to support.